We are live on ! Find out more
ACUR

Acura Pharmaceuticals
ACUR

Delisted

ACUR was delisted on the 22nd of February, 2017.

Back to rankings

2 hedge funds and large institutions have $352K invested in Acura Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more capital invested

Capital invested by funds: $215K → $352K (+$137K)

0% more funds holding

Funds holding: 2 → 2 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$352K – – –

ACUR Hedge Fund Activity: Q1 2019 in Review

2 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Acura Pharmaceuticals (ACUR) for Q1 2019, worth a combined $352K — up 64% from $215K a quarter earlier.

Fund positioning in ACUR was balanced in Q1 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Acura Pharmaceuticals (ACUR) as of Q1 2019, unchanged from Q4 2018.
  • Funds reported $352K of Acura Pharmaceuticals stock for Q1 2019, up 64% quarter-over-quarter.
  • 0 funds opened new Acura Pharmaceuticals positions in Q1 2019 and 0 closed out.

Based on aggregated 13F filings for Q1 2019.